GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8/A9
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Enteroendocrine cells relay energy-derived signals to immune cells to signal states of nutrient abundance and control immunometabolism. Emerging data suggest that the gut-derived nutrient-induced incretin glucose-dependent insulinotropic polypeptide (GIP) operates at the interface of metabolism and inflammation. Here we show that high-fat diet (HFD)-fed mice with immune cell-targeted GIP receptor (GIPR) deficiency exhibit greater weight gain, insulin resistance, hepatic steatosis and significant myelopoiesis concomitantly with impaired energy expenditure and inguinal white adipose tissue (WAT) beiging. Expression of the S100 calcium-binding protein S100A8 was increased in the WAT of mice with immune cell-targeted GIPR deficiency and co-deletion of GIPR and the heterodimer S100A8/A9 in immune cells ameliorated the aggravated metabolic and inflammatory phenotype following a HFD. Specific GIPR deletion in myeloid cells identified this lineage as the target of GIP effects. Furthermore, GIP directly downregulated S100A8 expression in adipose tissue macrophages. Collectively, our results identify a myeloid-GIPR-S100A8/A9 signalling axis coupling nutrient signals to the control of inflammation and adaptive thermogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistently, loss of GIPR signaling in mice is associated with enhanced adipose tissue inflammation, atherosclerosis, and mucositis (89–91).”
From Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits (2025) · cites this paper as [90]
In the citing paper
“On the other hand, the targeted deletion of GIP in myeloid immune cells resulted in increased inflammatory responses, suggesting that endogenous GIP may have an anti-inflammatory role [121].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [121]
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Self-citationBrown and beige fat: Development, function and therapeutic potential
Harms, M., & Seale, P. (2013) · Nature Medicine · doi:10.1038/nm.3361 · Cited by 2,328
Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Self-citationAdapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Wang, J., Vasaikar, S., Shi, Z., Greer, M., & Zhang, B. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx356 · Cited by 1,157
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963
Foell, D., Wittkowski, H., Vogl, T., & Roth, J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306170 · Cited by 879
Self-citationEhrchen, J. M., Sunderkötter, C., Foell, D., Vogl, T., & Roth, J. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008647 · Cited by 846
Self-citation
Cited by
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
Packer, M., Zile, M. R., Kramer, C. M., Baum, S. J., Litwin, S. E., Menon, V., Ge, J., Weerakkody, G. J., Ou, Y., Bunck, M. C., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2410027 · Cited by 1,009
Nauck, M. A., Quast, D. R., Wefers, J., & Pfeiffer, A. F. H. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14496 · Cited by 388
Wong, C. K., McLean, B. A., Baggio, L. L., Koehler, J. A., Hammoud, R., Rittig, N., Yabut, J. M., Seeley, R. J., Brown, T. J., & Drucker, D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.11.009 · Cited by 304
“Because GIPR agonism can attenuate inflammation in adipose tissue, macrophages, and brain, 66,67 it seems likely that tirzepatide reduces inflammation via both the GLP-1R and the GIPR in mice with LPS-induced inflammation.”
BackgroundSelf-citationBeyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1
Hammoud, R., & Drucker, D. J. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00783-3 · Cited by 244
“In HFD-fed mice, myeloid cell-specific deletion of Gipr leads to upregulated S100A8-dependent pro-inflammatory signalling in adipose tissue, impaired insulin action and reduced energy expenditure 65,66 .”
Self-citationThe expanding incretin universe: from basic biology to clinical translation
Drucker, D. J., & Holst, J. J. (2023) · Diabetologia · doi:10.1007/s00125-023-05906-7 · Cited by 243
Self-citation
Metadata
- Authors
- Mantelmacher, F. D., Zvibel, I., Cohen, K., Epshtein, A., Pasmanik-Chor, M., Vogl, T., Kuperman, Y., Weiss, S., Drucker, D. J., Varol, C., & Fishman, S.
- Affiliations
- Tel Aviv University (IL)
- University of Münster (DE)
- Weizmann Institute of Science (IL)
- Mount Sinai Hospital (CA)
- Corresponding author
- Fishman, Sigal
- ORCID
- Venue
- Nature Metabolism
- Published
- 2018-11-19
- Volume
- 1
- Issue
- 1
- Pages
- 58-69
- ISSN
- 2522-5812 (ISSN-L)
- OpenAlex
- W2900733792
- Cited by
- 70
- References
- 34
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 15 · 2023: 9 · 2022: 10 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 1
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Israel Science Foundation
- Canadian Institutes of Health Research (15432_1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucose-dependent insulinotropic polypeptide, GIP receptor, S100A8/A9, myeloid cells, adipose tissue macrophages, inflammation, obesity, high-fat diet, insulin resistance, hepatic steatosis, energy expenditure, white adipose tissue browning, thermogenesis, immunometabolism, myelopoiesis
- MeSH terms
- Animals, Body Weight, Bone Marrow, Gastric Inhibitory Polypeptide, Immunity, Immunohistochemistry, Inflammation, Insulin Resistance, Phenotype, Receptors, Gastrointestinal Hormone, Myeloid Cells, Myelopoiesis, Calgranulin A, Calgranulin B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8/A9. https://app.cochat.ai/papers/10.1038/s42255-018-0001-z
- The paper
- Mantelmacher, F. D., Zvibel, I., Cohen, K., Epshtein, A., Pasmanik-Chor, M., Vogl, T., Kuperman, Y., Weiss, S., Drucker, D. J., Varol, C., & Fishman, S. (2018). GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8/A9. Nature Metabolism. https://doi.org/10.1038/s42255-018-0001-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.